Answers are grounded in this paper and cite their sources.
In this issue, Owusu-Ofori and colleagues1 describe the use of rapid tests to screen potential blood donors for transfusion-transmitted diseases at a regional teaching hospital blood bank in Kumasi, Ghana. The authors report on the predonation testing of potential blood donors for human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B surface antigen before blood donation. Blood was subsequently collected only from donors who screened negative; pooled postdonation plasma samples were retested for HIV, hepatitis B virus (HBV), and HCV by nucleic acid amplification methods. In their study, the authors report that more than 16 percent of their tested potential donors reacted with one or more viral markers and could be prevented from donating blood. The author's suggestion of pooled nucleic acid testing as an adjunct to donor screening with rapid tests is an unusual and interesting algorithm, one that would be difficult to implement in many developing countries because of technologic issues and resource limitations. The authors argue, however, that there are a number of theoretical advantages to this strategy in areas of high endemicity for HIV, HBV, and HCV such as sub-Saharan Africa. The stated advantages include savings on the cost of blood collection bags that represent one-third of the blood bank budget; savings on the cost of the equipment needed for microtiter enzyme immunoassay (EIA); the ability to limit the storage of blood to that which has been screened as negative, thereby avoiding possible confusion over tested and untested blood; and the ability to inform deferred donors of their test results in regions where mail and telephone communication is poor and the likelihood of repeat donation is low. Throughout sub-Saharan Africa, blood centers routinely rely on high-prevalence donors such as family and/or replacement donors for a significant percentage of their blood collections. As a group these donors have higher prevalence rates of transfusion-transmitted diseases than volunteer donors. Therefore, collection centers with such high-prevalence populations find predonation testing strategies attractive from a cost- and resource-savings perspective. The practice of predonation screening of donors for HIV or hepatitis, usually with rapid tests, is not uncommon in some of these countries, particularly in the blood collection sites of small rural hospitals and clinics. The reasons commonly given for predonation testing usually include the cost and limited availability of blood collection bags, as stated above. Waste management issues are also a factor, because blood collection centers that test donors before donation may have fewer positive blood units to handle or discard. Unlike the study by Owusu-Ofori and coworkers, an additional level of postdonation screening is not usually performed in these centers, and the donated blood is transfused very soon after collection. In developing countries, the transmission of HIV and other blood-borne pathogens via blood transfusion is largely preventable by the establishment of nationally regulated, regional blood transfusion systems that provide an adequate supply of safe blood and through the elimination of unnecessary transfusions. The development of such regionalized systems, however, has been hampered by severe financial resource limitations. According to recent data from the World Health Organization, only 90 percent of blood donations in Africa in 2002 were screened for HIV, 55 percent for HBV, and only 40 percent for HCV.2 Therefore, from a cost-savings standpoint, the arguments for predonation screening do have some merit. The lowering of costs by predonation screening may be significant when transfusion-transmitted infection prevalences among donors range from 15 to 20 percent. Well-organized blood safety programs that depend mainly on voluntary nonremunerated blood donors and have established a repeat donor pool, however, should expect discard rates of less than 10 percent for all transfusion-transmitted infections. At this lower donor prevalence rate, there may be minimal cost savings from reduction of blood collection bag use, given the fact that rapid tests cost more than EIA tests. In addition to economics, however, we additionally consider some of the larger implications for predonation laboratory testing of blood donors. There are several reasons that blood collection centers should be hesitant to initiate the practice of predonation testing, reasons that may supersede cost savings. These reasons concern logistics, quality of blood banking and transfusion practice, donor confidentiality, donor counseling, and stigma. In Africa, blood is collected predominately from schools and other academic institutions and from factories or workplaces. Mobile blood collection teams are usually given a limited time, sometimes only 2 hours, to complete collections averaging 40 to 50 units. The task of predonation testing of 50 blood donors for HIV, HBV, HCV, and syphilis by rapid tests is quite daunting. At a properly operating blood drive, these clients should receive pre- and posttest counseling, followed by blood donation for those who screen negative. Blood donors may spend 2 hours at the blood donation clinic, discouraging them from returning for subsequent donations in the future and potentially reducing the support of schools and businesses for holding drives and/or clinics. When blood centers test donors at remote blood drive sites, all test results and patient data are collected manually during the predonation testing. The results must then be manually reentered at the blood center, increasing both the workload and the possibility of transcription errors. The general practice of predonation testing is of particular concern when carried out in small clinics and hospitals, owing to the lack of qualified staff, the lack of an organized recruitment system for volunteer donors, and the lack of a quality management system. In many situations, technologists with lower skill levels are able to perform donor testing with HIV rapid tests, but may not have the proficiency level to perform more complex tests or to guarantee that the other basic operations and functions of a proper transfusion service are carried out. The implementation of testing alone without providing proper oversight and education and without establishing quality-assurance programs is not effective. Although there are little data on rates of adverse transfusion events in developing countries, the combination of low technologist skill level and inadequate quality systems is of great concern. Blood transfusion practice is a complex area of medical care that carries potentially serious consequences when not practiced carefully. Even in developed countries with adequate resources, adverse events are not infrequent in transfusion practice. The blood from screened donors is often transfused very soon after collection, without the support of additional postdonation testing, as was done in the study by Owusu-Ofori et al. In this setting, testing errors can be significant, with false-negative rates of 1 to 2 percent or higher. False-negative tests in such high-prevalence donor populations translate into high rates of transfusion-transmitted infections. False-positive tests, without confirmatory testing, may lead to misdiagnosis of disease in a healthy donor. Counseling and referral in this setting may not be performed at all. When counseling is performed, it may be done poorly owing to insufficient and inadequately trained staff. Another reason for caution in the practice of predonation testing is that blood transfusion centers have the potential to become test sites for persons who simply want to know their HIV status. Voluntary counseling and testing centers (VCT) are set up in many resource-restricted countries with high HIV prevalence rates to allow persons to learn their HIV status and to provide them with counseling and prevention messages that may help identify and change risk behavior. Blood centers that test donors before donation place themselves at risk of becoming alternate VCT centers. Some persons may preferentially choose to be tested at blood transfusion centers rather than VCT centers, because there may be a lower perceived stigma in visiting a blood collection center than a VCT center. Blood centers that test donors before donation may therefore attract persons who primarily want to know their HIV status and, by inference, have behaviors that have put them at risk of HIV infection. The safety of the blood supply could then be compromised. For this reason, efforts should be made to separate the process of blood donation from the process of learning one's test status. As seen in the study by Owusu-Ofori and coworkers,1 the predonation screening process will inevitably disqualify many donors at the donation site. In countries with high HIV prevalence, there is a high suspicion by the public that any deferral is due to a positive HIV test result. Therefore, it may be assumed that any deferral, even for low hemoglobin, will be considered synonymous with being HIV+. The stigma attached to this label is well known and significant. Finally, adopting the practice of predonation testing, by itself, does not address the larger obligation of blood centers to establish a reliable donor recruitment system and to develop a pool of safe volunteer donors. In many resource-restricted countries, organized blood donor recruitment systems with networks of repeat donors are not common. The proposed practice of testing donors before donation does not address the larger problem of donor recruitment and selection. Rather than accepting high-risk donors as the norm, an organized blood system should attempt to develop strong programs of donor recruitment and selection and strong quality management. In the development of such systems, best practice would only allow blood collections in facilities with a sufficient scale of operation and with sufficient numbers of qualified staff to properly collect blood from a network of low-risk blood donors. The development of a pool of safe and reliable donors should be a primary goal for blood transfusion safety programs in resource-restricted countries, just as it in developed countries. In such systems, the practice of donors before donation would not have a significant role. Sustainable good-quality blood transfusion systems can only be achieved with national oversight and a commitment to safe blood transfusion as a part of the health-care system. This can only happen with the development of national and regionalized systems that have sufficient size and resources to operate properly. The development of a donor recruitment network should be an integral part of these systems.3 Some developing countries have made notable strides in the establishment of volunteer donor recruitment networks. Others should be encouraged to develop such systems.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: